Tucotuzumab celmoleukin

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Tucotuzumab celmoleukin ?
Monoclonal antibody
Type Whole antibody
Source Humanized (from mouse)
Target EpCAM
Clinical data
Legal status ?
Identifiers
CAS number 339986-90-2 YesY
ATC code None
KEGG D09027 YesY
Chemical data
Formula C7812H12124N2044O2408S60 
Mol. mass 175.1 kDa
 YesY (what is this?)  (verify)

Tucotuzumab celmoleukin is an anti-cancer drug. It is a fusion protein of a humanized monoclonal antibody (tucotuzumab) and an interleukin-2 (celmoleukin).[1][2][3]

This drug was developed by EMD Pharmaceuticals.

References[edit]

  1. ^ Statement On A Nonproprietary Name Adopted By The Usan Council - Tucotuzumab Celmoleukin, American Medical Association.
  2. ^ ClinicalTrials.gov
  3. ^ National Cancer Institute: Definition of tucotuzumab celmoleukin